Search

Your search keyword '"Kyriakopoulos CE"' showing total 1 results
Start Over Author "Kyriakopoulos CE" Publisher ame publishing company
1 results on '"Kyriakopoulos CE"'

1. Surrogate end points in early prostate cancer clinical states: ready for implementation?

Author

Kyriakopoulos CE and Antonarakis ES

Abstract

Competing Interests: Conflicts of Interest: ES Antonarakis is a paid consultant/advisor to Janssen, Astellas, Sanofi, Dendreon, Medivation, ESSA, AstraZeneca, Clovis and Merck; he has received research funding to his institution from Janssen, Johnson & Johnson, Sanofi, Dendreon, Genentech, Novartis, Tokai, Bristol Myers-Squibb, AstraZeneca, Clovis and Merck; and he is the co-inventor of a biomarker technology that has been licensed to Tokai and Qiagen. CE Kyriakopoulos has no conflicts of interest to declare.

Published
2017
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results